Helixmith Co., Ltd (KOSDAQ:084990)
South Korea · Delayed Price · Currency is KRW 3,540.00
-125.00 (-3.41%)
Aug 12, 2026, 1:55 PM KST
Helixmith Market Cap
Helixmith has a market cap or net worth of 168.76 billion as of August 11, 2026. Its market cap has decreased by -12.32% in one year.
Market Cap
168.76B
Enterprise Value
87.70B
Revenue
2.22B
Ranking
n/a
PE Ratio
n/a
Stock Price
3,540.00
ChartMarket Cap Chart
Since December 29, 2005, Helixmith's market cap has decreased from 238.64B to 168.76B, a decrease of -29.28%. That is a compound annual growth rate of -1.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 168.76B | -41.08% |
| Dec 30, 2025 | 286.41B | 130.37% |
| Dec 30, 2024 | 124.33B | -51.50% |
| Dec 28, 2023 | 256.37B | -35.45% |
| Dec 29, 2022 | 397.14B | -53.54% |
| Dec 30, 2021 | 854.88B | -3.11% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BINEX | 221.02B |
| GC Cell | 219.85B |
| EASY BIO,Inc. | 208.42B |
| HLB Therapeutics | 188.38B |
| Bioneer | 178.35B |
| Anterogen.Co.,Ltd. | 169.40B |
| JETEMA, | 162.20B |
| NeoImmuneTech | 151.17B |